Skip to main content
. 2015 Apr 13;10(4):e0123733. doi: 10.1371/journal.pone.0123733

Table 1. Patient characteristics.

Normal Microalbuminuria p value
(n = 24) (n = 21)
Age (year) 62.8 ± 11.8 62.6 ± 11.3 0.960
Male (%) 70.1 85.7 0.296
Hypertension (%) 75.0 71.4 1.00
Diabetes (%) 33.3 33.3 1.00
Dyslipidemia (%) 83.3 90.5 0.670
Current Smoker (%) 33.3 57.1 0.140
Prior CAD (%) 12.5 19.0 0.689
Killip III, IV (%) 4.2 19.0 0.169
GRACE RS 123.7 ± 31.6 141.4 ± 48.8 0.152
Systolic BP (mm Hg) 141.5 ± 26.3 147.7 ± 31.1 0.473
Heart rate (beats/min) 77.4 ± 18.3 82.7 ± 20.7 0.371
STEMI (%) 91.7 85.7 0.652
Anterior MI (%) 58.3 42.9 0.376
Onset-Balloon (min) 450.8 ± 434.4 405.8 ± 413.5 0.724
Stent (%) 95.8 95.2 0.611
IABP (%) 0 4.8 0.463
Final TIMI flow 3 (%) 95.8 95.2 1.00
CIN (%) 4.2 23.8 0.083
Medications (%)
β-blocker (%) 62.5 52.4 0.555
ACE-I (%) 45.8 28.6 0.356
ARB (%) 41.7 57.1 0.376
CCB (%) 33.3 28.6 0.759
Diuretic (%) 12.5 28.6 0.267
Statin (%) 87.5 76.2 0.443
Antiplatelet therapy (%) 95.8 100 1.00

CAD, coronary artery disease; GRACE RS, Global Registry of Acute Coronary Events risk score; BP, blood pressure; IABP, intra-aortic balloon pump; STEMI, ST elevation myocardial infarction; MI, myocardial infarction; TIMI, Thrombolysis in Myocardial Infarction; CIN, contrast induced nephropathy.